Furthermore, TMZ/siPD‐L1@GLPN/dsb also enhanced the sensitivity of in situ TMZ‐resistant GBM to TMZ by reducing the protein expression of MGMT in TMZ‐resistant GBM cells. This evidence concerns the gene MGMT and glioblastoma.